No Detail Found!

Redox Homeostasis and Antioxidant Dysregulation in Chronic Myeloid Leukemia: Biomarker Potential for Disease Progression and TKI Response

Author(s)
Hiba Al-Nayyar Biochemistry and Biotechnology Laboratory LR01ES05, Faculty of Sciences of Tunis, University of Tunis El Manar, El Manar II, Tunis 2092, Tunisia
Kamel Ben-Mahrez Biochemistry and Biotechnology Laboratory LR01ES05, Faculty of Sciences of Tunis, University of Tunis El Manar, El Manar II, Tunis 2092, Tunisia
Abstract
Background: The BCR-ABL fusion gene drives chronic Myeloid Leukemia (CML), resulting in an oncoprotein with excessive tyrosine kinase activity that promotes abnormal cell growth. Treatments with tyrosine kinase inhibitors (TKIs) induce oxidative stress, but resistance can develop due to compromised antioxidant defenses. Reactive oxygen species (ROS) play a dual role; low levels support cell signaling, while high levels cause damage. The body counters ROS through antioxidants enzymes. In cancer, malignant cells adapt by managing oxidative stress, influencing therapy response. Objectives: The present study aimed to investigate redox homeostasis and antioxidant defense regulation in patients with chronic myeloid leukemia (CML) by measuring the levels of catalase (CAT), superoxide dismutase (SOD), glutathione (GSH), and reactive oxygen species (ROS) in three groups of patients receiving different tyrosine kinase inhibitor (TKI) therapies, and compared them with newly diagnosed CML cases and healthy controls. Furthermore, we sought to assess the potential of these redox markers as biomarkers for disease progression and therapeutic response. Methods: Blood samples of 120 CML patients (20 newly diagnosed and 100 on TKI) and 60 healthy controls were analyzed via ELISA. Results: results showed a significant oncogene's redox-disrupting effects in CML patients characterized by decreased levels of (CAT, SOD, GSH) and increased ROS versus controls (all p<0.001). TKI treatment improved most markers (p<0.05) except GSH. Conclusions: These findings highlight the potential of antioxidant enzymes and ROS as biomarkers of disease progression and treatment response in CML, and support the relevance of redox homeostasis in therapeutic monitoring.
Publication Details
Page(s) 174-179
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 10, Year: 2025

Request the full text from PASTIC

Keywords
Oxidative stress, Antioxidants, Biomarkers, Redox Homeostasis, CML
References
Siegel R.L. .2025 .A Cancer Journal for Clinicians. Cancer Statistics, 75 : 10-45.
Arsalan H.M. .2023 .Prospective Biochemical Analysis of Chronic Myeloid Leukemia Patients in Response to Tyrosine Kinase Inhibitors. Pakistan Journal of Zoology, 55 : 2103-2111.
Allegra A.,Anti- A. .2024 .Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro-. Effects of Tyrosine Kinase Inhibitors.” Antioxidants, 13 : 461.
Azzi A.,Antioxidants A. .2022 .. , 11 : 1431-1442.
Sies H. .2023 .Oxidative Eustress: The Physiological Role of Oxidants. Science China Life Sciences, 66 : 1947-1948.
Chyad Z.S.,Matter A.D. .2024 .“Investigation and Assessment of Oxidant-Antioxidant Status of Some Enzymes and Vitamins in Iraqi Patients with Chronic Myeloid Leukemia. Current Issues in Pharmacy and Medical Sciences, 37 : 162-165.
Jomova K.,LowMolecular-Weight Antioxidants K. .2024 .Several Lines of Antioxidant Defense against Oxidative Stress: Antioxidant Enzymes, Nanomaterials with Multiple Enzyme-Mimicking Activities,. Free Radical Biology and Medicine, 98 : 1323-1367.
Cabrera-Serrano A.J.,Antioxidants A.J. .2025 .Crosstalk Between Autophagy and Oxidative Stress in Hematological Malignancies: Mechanisms, Implications,. , 14 : 264-315.
Forman .2014 .An Overview of Mechanisms of Redox Signaling. ” Journal of Molecular and Cellular Cardiology, 73 : 2-9.
Hegedűs C. .2018 .. Redox Control of Cancer Cell Destruction.” Redox Biology, 16 : 59-74.
Eras N. .2021 .An Investigation of the Relation Between Catalase C262T Gene Polymorphism and Catalase Enzyme Activity in Leukemia Patients. Archives of Medical Science: AMS, 17 : 928-933.
Ahmad R. .2012 .Leukocyte Superoxide Dismutase Activity in Patients with Chronic Myeloid Leukemia. , 34 : 394-395.
Valko M. .2007 .. Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease.” The International Journal of Biochemistry & Cell Biology, 39 : 44-84.
Dikic D. .2022 .Inflammation Promotes Oxidative and Nitrosative Stress in Chronic Myelogenous Leukemia. ” Biomolecules, 12 : .
Naz A. .2013 .Oxidative Stress and Total Antioxidant Status in Acute Leukemia at Diagnosis and Post Remission Induction Phase. Pakistan Journal of Pharmaceutical Sciences, 26 : 1123-1130.
Bakan N.,Glutathione Peroxidase,Cu-Zn Superoxide Dismutase Activities Nitric,Oxide Nitric .2003 .Malondialdehyde Concentrations in Serum of Patients with Chronic Lymphocytic Leukemia. International Journal of Clinical Chemistry, 338 : 143-149.
Zuo X.L. .2006 .Levels of Selenium, Zinc, Copper, and Antioxidant Enzyme Activity in Patients with Leukemia. ” Biological Trace Element Research, 114 : 41-53.
Polat M.F. .2002 .Oxidant/Antioxidant Status in Blood of Patients with Malignant Breast Tumour and Benign Breast Disease. ” Cell Biochemistry and Function, 20 : 327-331.
Trombetti S. .2021 .Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia. International Journal of Molecular Sciences, 22 : .
0

Citations

0

Downloads

42

Views